These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

77 related items for PubMed ID: 7529346

  • 21. Clinical evaluation of the i-STAT kaolin activated clotting time (ACT) test in different clinical settings in a large academic urban medical center: comparison with the Medtronic ACT Plus.
    Lewandrowski EL, Van Cott EM, Gregory K, Jang IK, Lewandrowski KB.
    Am J Clin Pathol; 2011 May; 135(5):741-8. PubMed ID: 21502428
    [Abstract] [Full Text] [Related]

  • 22. In vivo and in vitro evaluation of the heparin management test versus the activated coagulation time for monitoring anticoagulation level in aprotinin-treated patients during cardiac surgery.
    Kim YS, Murkin JM, Adams SJ.
    Heart Surg Forum; 2004 May; 7(6):E599-604. PubMed ID: 15769695
    [Abstract] [Full Text] [Related]

  • 23. Aprotinin and hemostasis monitoring concerns during cardiac surgery.
    Swartz MF, Fink GW, Searles B.
    J Extra Corpor Technol; 2004 Dec; 36(4):375-83. PubMed ID: 15679283
    [Abstract] [Full Text] [Related]

  • 24. Safety issues in heparin and protamine administration for extracorporeal circulation.
    Jobes DR.
    J Cardiothorac Vasc Anesth; 1998 Apr; 12(2 Suppl 1):17-20. PubMed ID: 9583571
    [Abstract] [Full Text] [Related]

  • 25. Kaolin-activated thromboelastography.
    Pivalizza EG, Warters RD.
    Anesthesiology; 2002 Sep; 97(3):758; author reply 759. PubMed ID: 12218558
    [No Abstract] [Full Text] [Related]

  • 26. Reduced blood loss following open heart surgery with aprotinin (Trasylol) is associated with an increase in intraoperative activated clotting time (ACT).
    Royston D, Bidstrup BP, Taylor KM, Sapsford RM.
    J Cardiothorac Anesth; 1989 Oct; 3(5 Suppl 1):80. PubMed ID: 2485224
    [No Abstract] [Full Text] [Related]

  • 27. Kaolin-based activated coagulation time measured by sonoclot in patients undergoing cardiopulmonary bypass.
    Ganter MT, Monn A, Tavakoli R, Klaghofer R, Zollinger A, Hofer CK.
    J Cardiothorac Vasc Anesth; 2007 Aug; 21(4):524-8. PubMed ID: 17678778
    [Abstract] [Full Text] [Related]

  • 28. Correlation between serum nafamostat mesilate and activated coagulation time during continuous hemodiafiltration.
    Nakae H, Tajimi K.
    Artif Organs; 2005 Apr; 29(4):352-4. PubMed ID: 15787634
    [Abstract] [Full Text] [Related]

  • 29. Activated clotting time, anticoagulation, use of heparin, and thrombin activation during extracorporeal circulation: changes under aprotinin therapy.
    Feindt P, Volkmer I, Seyfert U, Huwer H, Kalweit G, Gams E.
    Thorac Cardiovasc Surg; 1993 Feb; 41(1):9-15. PubMed ID: 7690165
    [Abstract] [Full Text] [Related]

  • 30. Response of kaolin ACT to heparin: evaluation with an automated assay and higher heparin doses.
    Despotis GJ, Alsoufiev AL, Spitznagel E, Goodnough LT, Lappas DG.
    Ann Thorac Surg; 1996 Mar; 61(3):795-9. PubMed ID: 8619695
    [Abstract] [Full Text] [Related]

  • 31. Guidelines for monitoring heparin by the activated clotting time when aprotinin is used during cardiopulmonary bypass.
    Hunt BJ, Segal HC, Yacoub M.
    J Thorac Cardiovasc Surg; 1992 Jul; 104(1):211-2. PubMed ID: 1377315
    [No Abstract] [Full Text] [Related]

  • 32. Activated clotting time measurements and aprotinin studies.
    Abramson DC, Pivalizza EG, Gottschalk LI.
    Circulation; 1996 Oct 01; 94(7):1791-2. PubMed ID: 8840885
    [No Abstract] [Full Text] [Related]

  • 33. [Clotting time and kaolin clotting time].
    Amagai H, Murakami M.
    Nihon Rinsho; 2004 Dec 01; 62 Suppl 12():581-3. PubMed ID: 15658394
    [No Abstract] [Full Text] [Related]

  • 34. Sonoclot coagulation analysis: a study of test variability.
    Ekbäck G, Carlsson O, Schött U.
    J Cardiothorac Vasc Anesth; 1999 Aug 01; 13(4):393-7. PubMed ID: 10468250
    [Abstract] [Full Text] [Related]

  • 35. Increased anticoagulation during cardiopulmonary bypass by aprotinin.
    de Smet AA, Joen MC, van Oeveren W, Roozendaal KJ, Harder MP, Eijsman L, Wildevuur CR.
    J Thorac Cardiovasc Surg; 1990 Oct 01; 100(4):520-7. PubMed ID: 1699088
    [Abstract] [Full Text] [Related]

  • 36. The effect of aprotinin on the response of the activated partial thromboplastin time (APTT) to heparin.
    Francis JL, Howard C.
    Blood Coagul Fibrinolysis; 1993 Feb 01; 4(1):35-40. PubMed ID: 7681330
    [Abstract] [Full Text] [Related]

  • 37. Kaolin clotting time.
    Radhakrishnan K.
    Methods Mol Biol; 2013 Feb 01; 992():335-9. PubMed ID: 23546725
    [Abstract] [Full Text] [Related]

  • 38. Effects of novel synthetic serine protease inhibitors on postoperative blood loss, coagulation parameters, and vascular relaxation after cardiac surgery.
    Szabó G, Veres G, Radovits T, Haider H, Krieger N, Bährle S, Miesel-Gröschel C, Niklisch S, Karck M, van de Locht A.
    J Thorac Cardiovasc Surg; 2010 Jan 01; 139(1):181-8; discussion 188. PubMed ID: 20106364
    [Abstract] [Full Text] [Related]

  • 39. [Effects of various adsorbants on coagulation factors (author's transl)].
    Soulier JP, Prou-Wartelle O.
    Nouv Rev Fr Hematol; 1975 Jan 01; 15(2):195-211. PubMed ID: 126430
    [Abstract] [Full Text] [Related]

  • 40. Efficacy of aprotinin in different doses and autologous blood transfusions in cardiac surgery.
    Gschossmann J, Pracki P, Struck E.
    Cardiovasc Surg; 1994 Dec 01; 2(6):716-9. PubMed ID: 7532087
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 4.